Member Info for Lankylad

The web site messages are unambiguous in that funds are already in escrow account and we have a completion date. Previous info gives amount received and number of shares in issue. I find it hard to believe its true but what possible motive could there be for anyone to put false information on company website?

Great research Myles. Your conclusions seem spot on to me. I think the TSG situation has weighed heavily on us particularly as the downstream possibilities were regularly promoted by the company. The valuation metrics would support us as an upstream producer alone.

Excellent news and well done Shishir and team.
Hopefully news soon on production to end of March (guidance 2500-2900 mt).
Then progress on TSG and we can finally see us re-rate?

Regarding the cost per mt, which has increased from £241 to £454 per mt. Normally with economies of scale you would expect this to drop. This suggests a lot of capital spending has been disallowed by auditors and has hit the current year as revenue expenditure. If we say, assume less of this to year end then I could see cost at say £300 per mt. If we hit 6000 mt production and sell all at £689 then we could hit ebitda of over £2m and operating profit of around £1m assuming modest increase in expenses. Anybody else got thoughts on next 6 months?

Just seen the news. Can’t believe it but why raise our hopes. Surely nothing to gain from ctag.
Does anyone know whether shares were reorganised or anything after delisting and off market fund raises.

6.5p

Looks like latest cyclone hit land south of us?

Can you please add me to party list. Been here since manic Monday and holding strong.

Was on the trail and have now subscribed for the product. For information I had initial good results and then plateaued a bit. After 6 weeks scaling on my knees improved dramatically and I have not used a steroid cream for 2 months. I had been using creams for around 40 years and on your knees it spoils your trousers and bedding as other sufferers will know. So all good for me and will add as funds come available.
Sales may be a slow burner and we may have to be patient but it does work for me.

The family have shown their ambition with IPO and then seeking OTC listing. Going private would limit them to organic growth. They are not going to cut off access to capital at this stage and even a 30% stake would ensure effective control. They are in for the long game in my opinion. Value will out in the medium term. All imho.

Hi J
The way I understand it we pay approx £10m for the assets and IP of Tsg including graphene tech. We also pay around £6m in terms of warrants (sp-40p) by year end. So we have approx an extra 16m shares dilution to set off against value of Tsg. Is TSG worth £16m? I think it is, so will top up if it goes towards 90p. DYOR of course.

All positive. Very good chairmans commentary. Can’t find any negatives. Will top up sub £1.20 when I have the cash.

Have done the research here and this looks such a good company in the making. Looking at SP keep thinking I must have missed something and would appreciate any insights. Could it be mistrust in mgt not being UK based or worries over approvals of downstream merger?

Trade and other receivables would be invoiced amounts not yet received at bs date i.e. 31st May. For sales you have to add amounts already received plus June invoices

Well done the Tirupati team. A real measurable achievement.

Thx jing. Very soon you would hope to be before end of this month?

First invested here more than 10 years ago after ceo presentation in Manchester. Cant remember ceo name but the pitch looked good and all we had were prospects. Sold out long ago before Tolgoi support and Shell cash. Company now looks in the best shape since then and to buy in sub 3p must be a gift for the patient investor. I bought in yesterday for first time in 8 years.

Everything looks to be on track. All hinges on FDA approval. We have plenty of cash to roll out product. Nice to see confidence in already recruiting sales staff so they are effective and ready for Q4.

On the latest twitter interview Sish states that plant is being commissioned whatever that means. Does seem that production is close though. In spite of covid issues?

Sorry excellent figures through pandemic. Interesting to see TSG figures when consolidated. Our cash supporting TSG expansion so misleading to quote cash with no offsetting revenue. They will probably need to raise in the autumn/winter but this company seem to make brilliant use of our cash.